Treatment and prevention of peritoneal carcinomatosis from colorectal cancer

Surgical Oncology Clinics of North America

Volumn 12, Issue 3, 2003, Pages 543-559

  Elias, Dominique M ^a   Pocard, Marc ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; LEVAMISOLE; MITOMYCIN; MITOMYCIN C; MITOXANTRONE; OXALIPLATIN;

ABDOMINAL RADIOGRAPHY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CLINICAL TRIAL; COLORECTAL CANCER; DIAGNOSTIC IMAGING; DRUG EFFICACY; HIGH RISK PATIENT; HUMAN; IMAGE ANALYSIS; MOLECULAR BIOLOGY; PATIENT SELECTION; PROGNOSIS; REVIEW; SURVIVAL TIME;

EID: 0042243637     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1055-3207(03)00049-8     Document Type: Review

References (40)

1. Rosen SA, Buell JF, Yohida A, Kazsaba S, Hurst R, Michelassi F, et al. Initial presentation with stage IV colorectal cancer. Arch Surg 2000;135:503-5.
2. Dawson LE, Russell AH, Tong D, Wisbeck W. Adenocarcinoma of the sigmoid colon: sites of initial dissemination and clinical patterns of recurrence following surgery alone. J Surg Oncol 1983;22:95-9.
3. Russel AH, Tong D, Dawson LE, Wisbeck W, Griffin TW. Adenocarcinoma of the retroperitoneal ascending and descending colon: sites of initial dissemination and clinical patterns of recurrence following surgery alone. Int Radiat Oncol Biol Phys 1983;9:361-5.
4. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997;336:980-7.
5. Brodsky JT, Cohen AM. Peritoneal seeding following potentially curative resection of colonic carcinoma: implications for adjuvant therapy. Dis Colon Rectum 1991;34:723-7.
6. Willet CG, Tepper JE, Cohen AM, Orlow E, Welch CE. Failure patterns following curative resection of colonic carcinoma. Surgery 1984;200:685-90.
7. Schott A, Vogel I, Kruger U, Kalthoff H, Schreider HW, Schmiegel W, et al. Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker. Ann Surg 1998;227:372-9.
8. Hansen E, Wolff N, Knuechel R, Ruschoff J, Hofstaedter F, Taeger K. Tumor cells in blood shed from the surgical field. Arch Surg 1995;130:387-93.
9. Cohen AM, Winawer SJ. Cancer of the colon, rectum, and anus. New York: McGraw-Hill; 1995.
10. Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis in non-gynecologic malignancy. Cancer 1989;63:364-7.
11. Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, et al. Peritoneal carcinomatosis from non-gynecologic malignancies. Multicentric prospective study. Cancer 2000;88:358-63.
12. Machover D. A comprehensive review of 5-fluorouracyl and leucovorin in patients with metastatic colorectal carcinoma. Cancer 1997;80:1179-87.
13. Isacoff WH, Borud K. Chemotherapy for the treatment of patients with metastatic colorectal cancer: an overview. World J Surg 1997;21:748-62.
14. Tournigand C, Louvet C, Quinaux E, et al. FOLFIRI followed by FOLFOX versus FOLFOX followed by FOLFIRI in metastatic colorectal cancer: final results of a phase III study. Proc Am Soc Clin Oncol 2001;20:124a.
15. Sugarbaker PH, Schellinx M, Chang D, Koslowe P, von Meyerfeldt M. Peritoneal carcinomatosis from adenocarcinoma of the colon. World J Surg 1996;20:585-92.
16. Beaujard AC, Glehen O, Caillot J, Francois Y, Bienvenu J, Panteix G, et al. Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer 2000;88:2512-9.
17. Marcus E, Weber TK, Rodrigues-Bigas MA, Driscoll D, Meropol NJ, Petrelli NJ. Prognostic factors affecting survival in patients with colorectal carcinomatosis. Cancer Invest 1999;17:249-52.
18. Zoetmulder FA. Cancer cell seeding during abdominal surgery: experimental studies. In: Sugarbaker PH, editor. Peritoneal carcinomatosis: principles of management. Boston: Kluwer Academic Publisher; 1996. p. 155-62.
19. Averbach AM, Sugarbaker PH. Methodologic considerations in treatment using intraperitoneal chemotherapy. In: Sugarbeker PH, editor. Peritoneal carcinomatosis: principles of management. Boston: Kluwer Academic Publisher; 1996. p. 289-309.
20. Los G, McVie JG. Experimental and clinical status of intraperitoneal chemotherapy. Eur J Cancer 1990;26:755-62.
21. Eilber FC, Rosen G, Forscher C, Scott DN, Dorey FJ, Eilber FR. Surgical resection and intraperitoneal chemotherapy for recurrent abdominal sarcomas. Ann Surg Oncol 1999;6:645-50.
22. Culliford AT, Brooks AD, Sharma S, Saltz LB, Schwartz GK, O'Reilly EM, et al. Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer. Ann Surg Oncol 2001;8:787-95.
23. Sugarbaker PH, Cuniffe W, Belliveau JF, de Bruin E, Graves T. Rationale for perioperative intraperitoneal chemotherapy as a surgical adjuvant for gastrointestinal malignancy. Reg Cancer Treat 1988;1:66-79.
24. Murakami A, Koga S, Macta M. Thermochemosensitivity: augmentation by hyperthermia of cytotoxicity of anticancer drugs against human colorectal cancer, measured by the human tumor clonogenic assay. Oncology 1988;45:236-41.
25. Shimizu T, Maeta M, Koga S. Influence of local hyperthermia on the healing of small intestinal anastomosis in the rat. Br J Surg 1991;78:57-9.
26. Dickson JA. Hyperthermia and laboratory animal systems. In: Proc. Int. Symp. Cancer Therapy by Hyperthermia and Radiation. Washington, DC: Am. Coll. Rad.; 1975. p. 105-6.
27. Elias D, Antoun S, Goharin A, El othmany A, Puizillout JM, Lasser PH. Research on the best chemohyperthermia technique for treatment of peritoneal carcinomatosis after complete resection. Int J Surg Invest 2000;1:431-9.
28. Sugarbaker PH. Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol 1998;14:254-61.
29. Sugarbaker PH. Intraperitoneal chemotherapy for treatment and prevention of peritoneal carcinomatosis and sarcomatosis. Dis Colon Rectum 1994;37(Suppl):S115-22.
30. Elias D, Blot F, El Otmany A, Antoun S, Lasser P, Boige V, et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001;92:71-6.
31. Elias D, Ouellet JF. Intraperitoneal chemohyperthermia. Rationale, technique, indications and results. Surg Oncol N Am 2001;10:915-33.
32. De Bree E, Witkamp AJ, Zoetmulder FA. Intraperitoneal chemotherapy for colorectal cancer. Review article. J Surg Oncol 2002;79:49-61.
33. Ceelen WP, Hesse B, de Hemptinne B, Pattyn P. Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer. A review. Br J Surg 2000;87:1006-15.
34. Sugarbaker PH. Treatment of pseudomyxoma peritonei. International Workshop on Peritoneal Carcinomatosis. Acad Romana Chirurg Rome; Oct. 13, 2001.
35. Loggie BW, Fleming RA, Mc Quellen RP, Russel GB, Geisinger KR. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin. Am Surg 2000;66:561-8.
36. Whitkamp AJ, de Bree E, Kaag MM, Boot H, Beijnen JH, van Slooten GW, et al. Extensive cytoreductive surgery followed by intraoperative hyperthermic intraperitoneal chemotherapy with mitomycin C in patients with peritoneal carcinomatosis from colorectal origin. Eur J Cancer 2001;37:979-84.
37. Pilati P, Mocellin S, Rossi CR, Foleto M, Campana L, Nitti D, et al. Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. Ann Surg Oncol 2003; in press.
38. Zoetmulder FA, Verwaal V, Ruth S. Hyperthermic intraperitoneal chemotherapy with mitomycin C significantly improves survival in patients with peritoneal carcinomatosis of colorectal origin. Proc Am Soc Clin Oncol 2002;21:147a.
39. Scheithauer W, Kornek GV, Marczell A, Karner J, Salem G, Greiner R, et al. Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs. fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma. Br J Cancer 1998;77:1349-54.
40. Vaillant JC, Nordlinger B, Deuffic S, Arnaud JP, Pelissier E, Favre JP, et al. Adjuvant intraperitoneal 5-FU in high-risk colon cancer. A multicenter phase III trial. Ann Surg 2000;231:449-56.